Chemours Company (CC)

전일 마감가:

$26.15

열려 있는:

$26.06

하루 거래량:

1.71M

시가총액:

$3.96B

수익:

$5.84B

순이익/손실:

$-330.00M

주가수익비율:

-13.22

EPS:

-2.01

순현금흐름:

$9.00M

1주 성능:

-2.75%

1개월 성능:

-7.52%

6개월 성능:

+3.47%

1년 성능:

-8.98%

1일 변동 폭

$26.06

$27.61

52주 변동 폭

$15.10

$39.05

Chemours Company Stock (CC) Company Profile

명칭

Chemours Company

부문

Basic Materials (270)

산업

Specialty Chemicals (67)

전화

302-773-1000

주소

1007 Market Street, Wilmington, DE

직원

7,000

트위터

@chemours

다음 수익 날짜

2024-05-21

최신 SEC 제출 서류

CC's Discussions on Twitter

Chemours Company Stock (CC) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-12-01	업그레이드	RBC Capital Mkts	Sector Perform → Outperform
2023-06-22	다운그레이드	BofA Securities	Buy → Neutral
2023-01-24	업그레이드	UBS	Neutral → Buy
2023-01-11	업그레이드	BofA Securities	Neutral → Buy
2023-01-10	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2022-11-01	개시	Credit Suisse	Underperform
2022-10-13	개시	Goldman	Neutral
2022-10-05	다운그레이드	Argus	Buy → Hold
2022-06-14	다운그레이드	BofA Securities	Buy → Neutral
2021-06-10	개시	Wolfe Research	Outperform
2021-06-09	업그레이드	Goldman	Neutral → Buy
2021-05-20	개시	BofA Securities	Buy
2021-05-06	업그레이드	Argus	Hold → Buy
2021-01-08	업그레이드	RBC Capital Mkts	Sector Perform → Outperform
2020-12-04	다운그레이드	Barclays	Overweight → Equal Weight
2020-11-30	개시	Alembic Global Advisors	Overweight
2020-03-23	다운그레이드	Jefferies	Buy → Hold
2020-02-14	업그레이드	CFRA	Buy → Strong Buy
2019-11-06	업그레이드	CFRA	Hold → Buy
2019-08-20	업그레이드	Susquehanna	Neutral → Positive
2019-08-09	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2019-08-06	다운그레이드	Argus	Buy → Hold
2019-08-05	다운그레이드	SunTrust	Buy → Hold
2019-07-12	다운그레이드	Citigroup	Buy → Neutral
2019-05-06	다운그레이드	JP Morgan	Overweight → Neutral
2019-04-15	업그레이드	SunTrust	Hold → Buy
2019-02-19	다운그레이드	Susquehanna	Positive → Neutral
2019-01-08	개시	HSBC Securities	Buy
2019-01-04	업그레이드	Citigroup	Neutral → Buy
2018-11-02	다운그레이드	Citigroup	Buy → Neutral
2018-07-18	개시	RBC Capital Mkts	Outperform
2018-01-30	개시	Morgan Stanley	Equal-Weight
2017-12-06	다운그레이드	Goldman	Buy → Neutral
2017-08-07	업그레이드	UBS	Sell → Neutral

모두보기

Chemours Company 주식(CC)의 최신 뉴스

Chemours (CC) Earnings Beat, Revenues Miss Estimates in Q1

Zacks Investment Research

Chemours (CC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment Research

Chemours (CC) Q1 Earnings Surpass Estimates

Zacks Investment Research

Chemours (CC) Up 2.9% Since Last Earnings Report: Can It Continue?

Zacks Investment Research

Stepan Co. (SCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks Investment Research

Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for

Zacks Investment Research

Chemours Company (CC) 재무 분석

Chemours Company (CC) 매출 2024

Chemours Company (CC) 순이익 2024

Chemours Company (CC) 현금흐름 2024

Chemours Company (CC) 주당 순이익 2024